By contrast, double blockade of IL-17A and IL-22 reduced colitis severity, indicating that these cytokines may play a redundant role in driving intestinal inflammation possibly through shared effects on intestinal epithelial cells (Liang et al., 2006). The gene discussed is IL17A; the disease is colitis.